Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Cash Incentives, Peer Support May Not Incentivize HCV Treatment

A randomized trial comparing a cash incentive to peer support for increasing acceptance of treatment for hepatitis C virus (HCV) among persons with HCV/HIV coinfection, including those who use drugs or alcohol, found both methods helpful but that 1 in 4 patients still declined treatment.

Published
10 May 2019
From
MD Magazine
NHS trumpets Hep C deal, quietly drops 2025 elimination target after legal row

NHS England has announced a deal with AbbVie, Gilead, and Merck, Sharpe and Dohme (MSD) that aims to eliminate hepatitis C from the country – although it has had to drop a 2025 target date because of a legal row during the procurement process.

Published
30 April 2019
From
pharmaphorum
NHS England strikes world leading deal to help eliminate hepatitis C

The NHS will find and cure tens of thousands more people with hepatitis C as part of a ground-breaking deal that could help England become the first country in the world to eliminate the deadly virus.

Published
30 April 2019
From
NHS England
Previous HAV vaccination does not reliably protect some patients with HIV

Study findings suggest that previous vaccination against hepatitis A virus infection does not reliably protect some people with HIV.

Published
18 April 2019
From
Healio
England hits WHO 2020 hepatitis C target three years early

Deaths from liver disease related to serious hepatitis C (HCV) fell by more than 16% between 2015 and 2017, according to data published by Public Health England (PHE). As a result, England has hit the World Health Organization’s (WHO’s) target to reduce HCV related mortality by 10% by 2020 three years early.

Published
18 April 2019
From
The Pharmaceutical Journal
Hepatic Steatosis Highly Prevalent in Young Adults With Lifelong HIV

One-third of young adults living with HIV since birth or early childhood have hepatic steatosis.

Published
17 April 2019
From
Infectious Disease Advisor
Health expert says hepatitis C could be eliminated quickly in Scotland

A leading expert in hepatitis C has said it could be removed from Scotland in the next five years if efforts to cure people were "energised".

Published
12 April 2019
From
BBC News
Summary from CROI 2019 for viral Hepatitis, from Jürgen Rockstroh

Although no new drugs for HBV or HCV therapy were presented a whole range of important clinical studies were discussed which all have important clinical implications for daily practice.

Published
09 April 2019
From
NATAP
Hepatitis C deaths fall by 16 per cent between 2015 and 2017

Deaths from serious hepatitis C related liver disease fell by 16.1% between 2015 and 2017 according to data from PHE.

Published
09 April 2019
From
Public Health England
Armenia gets license to produce drugs for hepatitis C treatment

The Armenian Ministry of Health and the Gilead Science Ireland UC have signed a Memorandum of Understanding, under which Gilead will provide Armenia with a license to produce, pack and import genetic drugs for hepatitis C treatment.

Published
03 April 2019
From
Public Radio of Armenia
← First12345...155Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.